Possible reduction of cardiac risk after supplementation with epigallocatechin gallate and increase of ketone bodies in the blood in patients with multiple sclerosis. A pilot study

  1. Benlloch, M.
  2. Cuerda‐ballester, M.
  3. Drehmer, E.
  4. Platero, J.L.
  5. Carrera‐juliá, S.
  6. López‐rodríguez, M.M.
  7. Ceron, J.J.
  8. Tvarijonaviciute, A.
  9. Navarro, M.Á.
  10. Moreno, M.L.
  11. Ortí, J.E.L.R.
Aldizkaria:
Nutrients

ISSN: 2072-6643

Argitalpen urtea: 2020

Alea: 12

Zenbakia: 12

Orrialdeak: 1-14

Mota: Artikulua

DOI: 10.3390/NU12123792 GOOGLE SCHOLAR lock_openSarbide irekia editor